Turgay ŞİMŞEK, Abdullah GÜNEŞ, Ümit BİLGİLİ, Erdem OKAY, Yeşim GÜRBÜZ, Volkan TEMİ, Mustafa ÇEKMEN

Resveratrol Attenuates Both Small Bowel and Liver Changes in Obstructive Jaundice

Background:It is wellknown thatmucosal changes andalterationsin liverfunction occur in theexperimental obstructive jaundice model.Aims:Weaimed to evaluate theeffect ofresveratrol onobstructive jaundice-induced changes in thesmall bowel mucosa andliverusing ischaemia-modified albumin as a marker of oxidative damage. Study Design: Animal experimentation.Methods:Thestudy useda rodent experimental model of obstructive jaundice, including a sham group (1),a control group (2),anda study group (3).Wistar albino ratswere used. Jaundice wasproduced by ligation ofthebileductinGroups 2 and3. InGroup 3, resveratrol was administered intraperitoneally for 14 days. Results:Interms ofthestructure andthesizeofthemucosal villi, significant thickening andblunting were detected inGroup 2 com-pared withGroup 1. These changes weresignificantly lessnoticeable inGroup 3 compared withGroup 2.Levels ofischaemia-modified albumin weresignificantly higher in Group 2 compared withthose in Group 1, andtheyweresignificantly decreased in Group 3 compared with Group 2. Conclusion:Resveratrol administration to obstructive jaundiced rats reduced theorganic effects ofobstructive jaundice onsmall bowel mucosa andliver oxidative stress. Webelieve thatthisreduction might attenuate bacterial translocation andsystemic effects ofse-creted cytokines.

PDF

___

Gonzalez-Correa JA, De La Cruz JP, Martin-Aurioles E, Lopez-Egea MA, Ortiz P, Sanchez de la Cuesta F. Effects of S-adenosyl-L-methio- nine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats. Hepatology 1997;26:121-7. [CrossRef]
Singh S, Shackleton G, Ah-Sing E, Chakraborty J, Bailey ME. An- tioxidant defenses in the bile duct-ligated rat. Gastroenterology 1992;103:1625-9.
Sokol RJ, Devereaux M, Khandwala RA. Effect of dietary lipid and vita- min E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res 1991;32:1349-57.
Cantürk NZ, Canturk Z, Utkan NZ, Yenisey C, Ozbilim G, Yildirir C, et al. Cytoprotective effects of alpha tocopherol against liver injury induced by extrahepatic biliary obstruction. East Afr Med J 1998;75:77-80.
Yamauchim N, Kuriyama H, Watanabe N, Neda H, Maeda M, Niitsa Y. Intracelluler hydroxyl radical production induced by recombinant hu- man tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res 1989;49:1671-5.
Galicia-Moreno M, Favari L, Muriel P. Antifibrotic and antioxidant ef- fects of n-acetylcysteine in an experimental cholestatic model. Eur J Gastroenterol Hepatol 2012;24:179-85. [CrossRef]
Krahenbuhl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxida- tive capacity in liver mitochondria from bile duct ligated rats. Hepatol- ogy 1995;22:607-12. [CrossRef]
Sgambato A, Ardito R, Faraglia B, Boninsegna A, Wolf FI, Cittadini A. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res 2001;496:171-80. [CrossRef]
Burkitt MJ, Duncan J. Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl- radical scavenging and a novel, glutathione-sparing mechanism of ac- tion. Arch Biochem Biophys 2000;381:253-63. [CrossRef]
Chen CY, Tsai WL, Lin PJ, Shiesh SC. The value of serum ischemia- modified albumin for assessing liver function in patients with chronic liver disease. Clin Chem Lab Med 2011;49:1817-21. [CrossRef]
Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin bind- ing and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-5. [CrossRef]
Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Evaluation of ischaemia-modified albumin as a marker of myocardial isch- aemia in end-stage renal disease. Clin Sci (Lond) 2007;113:25-32. [CrossRef]
Chan B, Dodsworth N, Woodrow J, Tucker A, Haris R. Site-specific N-terminal auto-degradation of human serum albumın. Eur J Biochem 1995;227:524-8. [CrossRef]
Parks RW, Stuart Cameron CH, Gannon CD, Pope C, Diamond T, Row- lands BJ. Changes in gastrointestinal morphology associated with ob- structive jaundice. Pathol 2000;192:526-32. [CrossRef]
Assimakopoulos SF, Thomopoulos KC, Patsoukis N, Georgiou CD, Scopa CD, Nikolopoulou VN, et al. Evidence for intestinal oxidative stress in pa- tients with obstructive jaundice. Eur J Clin Invest 2006;36:181-7. [CrossRef]
Kuzu MA, Kale IT, Cöl C, Tekeli A, Tanik A, Köksoy C. Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroen- terology 1999;46:2159-64.
Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol 2012;56:1283-92. [CrossRef]
Assimakopoulos SF, Tsamandas AC, Louvros E, Vagianos CE, Nikolo- poulou VN, Thomopoulos KC, et al. Intestinal epithelial cell prolifera- tion, apoptosis and expression of tight junction proteins in patients with obstructive jaundice. Eur J Clin Invest 2011;41:117-25. [CrossRef]
Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992;15:1132-6. [CrossRef]
Wang P, Gong G, Wei Z, Li Y. Ethyl pyruvate prevents intestinal in- flammatory response and oxidative stress in a rat model of extrahepatic cholestasis. J Surg Res 2010;160:228-35. [CrossRef]
Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY. Free radical- triggered hepatic injury of experimental obstructive jaundice of rats in- volves overproduction of proinflamatory cytokines and enhanced activa- tion of nuclear factor kappaB. Ann Clin Lab Sci 2001;31:383-90.
Hennet T, Richter C, Peterhans E. Tumour necrosis factor-alpha induces superoxide anion generation in mithocondria of L929 cells. Biochem J 1993;289:587-92.
Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Antioxidant en- zyme status in biliary obstructed rats:effects of N-acetylcysteine. J Hep- atol 1997;27:363-70. [CrossRef]
Ara C, Kirimlioglu H, Karabulut AB, Coban S, Ay S, Harputluoglu M, et al. Protective effect of resveratrol against oxidative stress in cholestasis. J Surg Res 2005;127:112-7. [CrossRef]
Kirimlioglu V, Ara C, Yilmaz M, Ozgor D, Isik B, Sogutlu G, et al. Resveratrol, a red wine constituent polyphenol, protects gastric tissue against the oxidative stress in cholestatic rats. Dig Dis Sci 2006;51:298- 302. [CrossRef]
Rubiolo JA, Mithieux G, Vega FV. Resveratrol protects primary rat he- patocytes against oxidative stress damage: activation of the Nrf2 tran- scription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 2008;591:66-72. [CrossRef]
Stillman AE, Giordano GF. Spur cell anemia associated with extrahe- patic biliary tract obstruction. Am J Gastroenterol 1983;78:589-92.
Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of "isch- emia modified albumin," a new biochemical marker of myocardial isch- aemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34. [CrossRef]
Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, et al. Associations among metabolic syndrome, isch- emia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocri- nol Metab 2010;95:586-91. [CrossRef]
Mentese A, Turkmen S, Karaguzel E, Karaca Y, Tatli O, Sumer AU, et al. The predictive value of ischemia-modified albumin in long-term re- sults of ischemia-reperfusion injury in an experimental testicular torsion model. Urology 2012;80:689-94. [CrossRef]